Baskadia

Parkinson’s Disease is a slowly degenerative disorder of the nervous system. Parkinson’s is characterized by its effect on the brain’s production of the neurotransmitter, Dopamine. Dopamine is responsible for voluntary muscle control. This disorder is origin at the brain and is expressed at the neurological level. Parkinson’s Disease is best characterized by tremors, weakness, and an inability to control posture and maintain a stable balance.

The use of Anti-Parkinsonian strategies is paramount in the management of the effects of the disease on the quality of life of a patient. While there is no known curative strategy for the permanent remission of the disease, Anti-Parkinsonian modern approaches provide a large array of strategies to slow its progression and provide functional support for affected patients. These strategies are aimed at the restoration of the balance of dopamine in the brain as well as encourage better communication among neurons. This progression will assist in delaying the need for increased support and assistive devices for patients.

Recently, the field of Adavancements in Neurology has developed many medications and Anti-Parkinsonian drugs which ease the management of the symptoms of the disease and address safety concerns regarding their use. Clinical practitioners create more integrative management plans for their patients incorporating medications, lifestyle and balance therapies, as well as support to provide to patients at all levels of the disease.

Overview of Parkinson’s Disease

Parkinson’s Disease is primarily a disorder of the central nervous system. The disease is self-evident in its slow and silent progression. Initially, the early symptoms may be of inconsequential order, and may go unnoticed. These may include tremors, slowness, rigidity, changes in motor skills, and difficulty maintaining postural control and balance.

Some of the common challenges patients face during the progression of the disease are difficulties in speech and swallowing, disturbances in sleep, anxiety and depression, and memory issues. The causes of Parkinson’s disease are not well understood, but environmental and genetic factors are believed to be involved.

Since everyone’s symptoms from this disease differ, treatment becomes really tricky. Anti-Parkinsonian therapies aim to control symptoms while balancing the effects of the medications.

Importance of Anti-Parkinsonian Therapies

These types of medications are important for the management of the diverse symptoms of this disease. Some of these symptoms include difficulties in movement, muscles, coordination, and even daily tasks. The earlier treatments are started, the greater the chances for the patient to maintain independence.

The main objective of the therapy is to increase the levels of dopamine in the brain, or to mimic the effect of dopamine. Some of the medication replace lost dopamine, while others slow the breakdown of dopamine or stimulate the receptors in the brain.

Often a combination of these therapies is essential, and are designed for each individual patient based on several factors such as age, the symptoms present, and disease severity.

Common Types of Anti-Parkinsonian Medications

Levodopa-Based Therapy

Levodopa-based therapy is the most widely used medication in the treatment of Parkinson’s disease. It is used because once it crosses the brain, it becomes dopamine.

This type of therapy is often used with carbidopa, which is the class of medications used to decrease the peripheral breakdown of levodopa and to decrease the side effects of this medication such as nausea and vomiting.

Patients taking levodopa generally have less tremors, stiffness and slowness. With more extended use, patients show fluctuations in control of symptoms, and new involuntary movements called dyskinesia appear.

​Dopamine Agonists

Dopamine agonists are drugs that help dopamine pathways in the brains by either replacing dopamine or stimulating dopamine receptors.

They are often used in the early stages of Parkinson’s disease and with levodopa in the later stages. Dopamine agonists may possibly lower the doses of levodopa and decrease the motor fluctuations.

Though helpful, these drugs may result in drowsiness, hallucinations, dizziness, and compulsive behaviors.

​MAO-B Inhibitors

Inhibitors of monoamine oxidase B help with the lack of dopamine in the brains, leading to a decrease in symptoms of the disease that come with an increase in the effectiveness of the levodopa therapy.

These inhibitors are found in earlier stages of the disease and with other therapies for longer relief of symptoms.

​COMT Inhibitors

Catechol-O-methyltransferase inhibitors have the opposite effect and help with the breakdown of levodopa, leading to longer usage of the levodopa therapy.

These drugs are helpful for patients with the ‘wearing-off’ effect of levodopa.

​Anticholinergic Medications

Anticholinergic drugs are often used for tremor and stiffness reduction. However they are more effective with younger patients, and for older patients, side effects on cognition may appear.

Amantadine

Amantadine is used to help treat involuntary movements from long-term Levodopa use. It can even help with tremors and stiffness.

More Options

As Parkinson's develops, there are options to help control these symptoms as well as decrease the negative side effects of these medications.

Deep Brain Stimulation

Deep brain stimulation places electrodes into the brain to reset the signals that are malfunctioning in the brain because of Parkinson's.

For patients who are not responding to medications, D.B.S. is a great option to help with stiffness and varying degrees of tremors.

Infusion Therapies

Unlike taking pills, these therapies continuously deliver medications to help with motor and symptom control. They are especially helpful for advanced Parkinson's who have a hard time controlling their symptoms.

Rehabilitative Services

Regular movement, strength, and skill training can help control and maintain physical status and mobility.

If patients have hard time communicating or even swallowing, speech therapy can be beneficial. Occupational therapy can help them perform their daily needs without assistance.

Lifestyle Changes

Along with medications, simple lifestyle changes can improve the treatment for this chronic ailment.

To stay healthy and energized, it is important to have a healthy diet. With regular simple exercises for stretching and walking, you can improve mobility and reduce stiffness.

An individual’s stresses and emotional issues can affect symptoms and need to be managed. Relaxation and participation in support groups can help improve emotional issues.

The management of a long-term medical condition also depends on the family. It is important for the family and health professionals to work together to assure that medications are taken and symptoms are monitored to ensure safety.

Challenges in Parkinson's Disease Treatment

While anti-Parkinsonian therapies are very beneficial to patients, there are still many forms that are problematic. Many of these symptoms can change and worsen on their own. These also depend on medications that are taken.

Symptoms that are worse include levodopa, which may cause symptoms that are not under control, and medications taken to help older patients that cause confusion, or even hallucinations and lower blood pressure.

The progression of Parkinson's Disease varies for each individual. Thus, it remains important to monitor and evaluate both the progression of the disease, and how effective the current treatments are.

It is all but certain that the frontier of Parkinson's research in particular and medicine in general is creativity. Neuroprotection, stem cells, and especially gene therapy hold promise as cutting-edge interventions that may delay the length of suffering.

The future of Anti-Parkinsonian therapies

The scope of anti-Parkinsonian therapies places great focus on improving treatments that address the core of symptoms.

Researchers are looking for methods to stop the impact of neurodegenerative diseases on the brain, if not fully restore function. Development of advanced stem and drug delivery systems, as well as enhanced neuromodulation, may yield better results and more meaningful solutions.

AI (artificial intelligence) and modern digital devices are being integrated into the management of Parkinson's disease. Digital devices offer better quality and accuracy in monitoring symptoms, medication responses, and patients' activities.

As treatments advance, the hope is to slow, halt, and if possible, completely stop the progression of the disease.

Conclusion

A multidisciplinary treatment approach is essential for the effective management of Parkinson's disease. Part of this approach includes the use of anti-Parkinsonian medications, supportive therapies, rehabilitation, and lifestyle changes among other things. More modern treatment modalities have led to an unprecedented improvement in the ability of patients to lead a more independent lifestyle, maintain their mobility, and achieve a better quality of life.

Levodopa therapy, dopamine agonists, MAO-B inhibitors, and other advanced treatments such as deep brain stimulation, remain central to symptom relief. Beyond essential medical treatment, physical activity, emotional support, and proper nutrition play an important role in the quality of life of patients.

Despite its chronic and progressive nature, Parkinson's disease is being redefined by modern medicine and patient outcomes. With the right treatment, and an appropriate amount of time, patients with Parkinson's disease can aspire to lead more active and fulfilling lives.